|
- 品牌：MedKoo
- 產(chǎn)地：美國
- 貨號：207118
- cas：197723-00-5
- 發(fā)布日期： 2022-07-20
- 更新日期： 2024-08-12
| 產(chǎn)地 | 美國 |
| 品牌 | MedKoo |
| 貨號 | 207118 |
| 用途 | This product is for research use only, not for human or veterinary use. |
| 包裝規(guī)格 | 5.0mg; 10.0mg; |
| CAS編號 | 197723-00-5 |
| 純度 | >98%% |
| 是否進口 | 是 |
Description: NKP-1339, aslo known as IT-139 and KP-1339, is a ruthenium-based anticancer drug in clinical development against solid cancer with limited side effects. NKP-1339 shows promising results in solid tumors, such as non-small cell lung cancer, colorectal carcinoma, and most distinctively in gastrointestinal neuroendocrine tumors.
Name: NKP-1339
CAS#: 197723-00-5
Chemical Formula: C14H12Cl4N4NaRu
Exact Mass:
Molecular Weight: 502.1378
Elemental Analysis: C, 33.49; H, 2.41; Cl, 28.24; N, 11.16; Na, 4.58; Ru, 20.13
Synonym: NKP-1339; NKP 1339; NKP1339; IT-139; IT 139; IT139; KP-1339; KP 1339; KP1339; Na[trans-RuCl4(Ind)2; sodium trans-[RuCl4(HInd)2,
IUPAC/Chemical Name: Sodium hydride; tetrachloro-bis(1H-indazol-2-yl)ruthenium
InChi Key: WVVOCRYXBTVDRN-UHFFFAOYSA-J
InChi Code: WVVOCRYXBTVDRN-UHFFFAOYSA-J
SMILES Code: [Cl-][Ru+3]([N]1=CC2=CC=CC=C2N1)([Cl-])([Cl-])([N]3=CC4=CC=CC=C4N3)[Cl-].[Na+]
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
